Literature DB >> 25914042

Recurrence of Ocular Surface Squamous Neoplasia Treated With Excisional Biopsy and Cryotherapy.

Albert S Li1, Carolyn Y Shih2, Lisa Rosen3, Anne Steiner2, Tatyana Milman4, Ira J Udell2.   

Abstract

PURPOSE: To evaluate the recurrence rate of ocular surface squamous neoplasias (OSSN) after excision and cryotherapy in an academic cornea practice and to determine factors associated with recurrence.
DESIGN: Retrospective interventional case series.
METHODS: All cases of OSSN from 1998 through 2013 that were treated with excisional biopsy and adjunctive cryotherapy were retrospectively reviewed. Clinical characteristics upon presentation including size of lesion, location, and atypical features were noted. All recurrences of OSSN after excision and cryotherapy were noted and categorized in relation to clinical characteristics, pathologic grade, and margin involvement.
RESULTS: Forty-three cases of OSSN from 42 patients were analyzed with a median follow-up of 29 months. A total of 32.6% of subjects had dysplasia and 67.4% had squamous cell carcinoma (SCC). A total of 83.7% of subjects had both corneal and conjunctival involvement while 16.3% had conjunctival involvement only. Overall, 3 recurrences were observed, all of which had margin involvement; nonetheless, the majority of incompletely excised OSSN (25/28) showed no recurrence. The recurrence rate at 6 months was 2.3%. Recurrence at 1 year, 2 years, and 5 years remained stable at 7.1%.
CONCLUSIONS: Excision with cryotherapy is an effective treatment for the majority of OSSN cases, even among cases with pathologic evidence of tumor at the margin, with an overall recurrence rate of 7.1% at 1 year, 2 years, and 5 years.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25914042     DOI: 10.1016/j.ajo.2015.04.027

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Characteristics, management, and outcome of squamous carcinoma of the conjunctiva in a single tertiary cancer center in Jordan.

Authors:  Ata Rajeh; Fareed Barakat; Samer Khurma; Khaleel AlRawashdeh; Osama H Ababneh; Ibrahim AlNawaiseh; Mustafa Mehyar; Ghadeer Abdeen; Imad Jaradat; Mona Mohammad; Yacoub A Yousef
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

Review 2.  Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva: Literature Review and Case Reports.

Authors:  Peter S Fagerberg; Ingvild M S Ramberg; Peter B Toft
Journal:  Ocul Oncol Pathol       Date:  2021-01-11

Review 3.  Ocular surface squamous neoplasia: management and outcomes.

Authors:  Roland Hӧllhumer; Susan Williams; Pamela Michelow
Journal:  Eye (Lond)       Date:  2021-02-09       Impact factor: 4.456

4.  Lack of relationship between cigarette smoking and alcohol use with dysplasia grade in ocular surface squamous neoplasia.

Authors:  Alison D Early; Sarah Adelson; Craig J Miller; Thomas F Mauger
Journal:  Clin Ophthalmol       Date:  2018-10-01

5.  AS-OCT Guided Treatment Of Diffuse Conjunctival Squamous Cell Carcinoma With Resection, Amniotic Membrane Graft And Topical Mitomycin C.

Authors:  Tarek Roshdy Elhamaky; Ahmed Mohammed Elbarky
Journal:  Clin Ophthalmol       Date:  2019-11-20

6.  Management Issues in Conjunctival Tumours: Ocular Surface Squamous Neoplasia.

Authors:  Victoria M L Cohen; Roderick F O'Day
Journal:  Ophthalmol Ther       Date:  2019-11-23

7.  Recurrent Conjunctival Squamous Cell Carcinoma and Intraocular Tumor Extension after Topical Erythropoietin: A Case Report.

Authors:  Sepehr Feizi; Hamed Esfandiari
Journal:  Case Rep Ophthalmol       Date:  2022-02-14

8.  Cost-effective treatment of ocular surface squamous neoplasia for an undocumented and uninsured New York City patient: a case report.

Authors:  Norman A Saffra; Trisha S Emborgo; Codrin E Iacob; David S Kirsch
Journal:  J Med Case Rep       Date:  2020-10-02

9.  Ocular surface squamous neoplasia in Northern Thailand: a 16-year review.

Authors:  Napaporn Tananuvat; Muanploy Niparugs; Damrong Wiwatwongwana; Nirush Lertprasertsuk; Pongsak Mahanupap
Journal:  BMC Ophthalmol       Date:  2022-03-12       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.